Contact Information
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Mark A. Ranalli
Biography
Dr. Ranalli’s clinical and academic interests include the treatment of neuroblastoma, primary renal tumors, germ cell malignancies, melanoma, and the use of novel therapies for refractory malignancies. He is the medical director of the Surgical Oncology Clinic and oversees the Embryonal Tumor Program. Dr. Ranalli received his medical degree from the University of Chicago Pritzker School of Medicine. He completed his residency at Children’s Hospital of Philadelphia and his fellowship training at Children’s Memorial Hospital in Chicago. Dr. Ranalli currently leads the therapeutic MIBG program and is the Nationwide Children’s site principal investigator for the Children’s oncology group.
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Nationwide Children’s Hospital Toledo
Mansfield Close To Home Center
Academic and Clinical Areas
Surgical Oncology Clinic
Co-Director
Melanoma & Pigmented Lesion Clinic
Physician Lead
Pediatric Thyroid Program
Physician Team
Hematology/Oncology & BMT
Physician Team
Hematology, Oncology and BMT Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
Research
Publications
Reed S, Treinen C, Shah N, Ranalli M, Olshefski R. Utilizing a Quality Improvement Strategy to Increase Faculty Engagement with Resident Learning Goals. Acad Pediatr. 2022 Sep 16;
Koo SC, Schieffer KM, Lee K, Gupta A, Pfau RB, Avenarius MR, Stonerock E, LaHaye S, Fitch J, Setty BA, Roberts R, Ranalli M, Conces MR, Bu F, Mardis ER, Cottrell CE. EGFR internal tandem duplications in fusion-negative congenital and neonatal spindle cell tumors. Genes Chromosomes Cancer. 2022 Jul 7;
Miller KE, Wheeler G, LaHaye S, Schieffer KM, Cearlock S, Venkata LPR, Bravo AO, Grischow OE, Kelly BJ, White P, Pierson CR, Boué DR, Koo SC, Klawinski D, Ranalli MA, Shaikhouni A, Salloum R, Shatara M, Leonard JR, Wilson RK, Cottrell CE, Mardis ER, Koboldt DC. Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement. Front Oncol. 2022; 12: 932337.
Koo SC, LaHaye S, Kovari BP, Schieffer KM, Ranalli MA, Aldrink JH, Michalsky MP, Colace S, Miller KE, Bedrosian TA, Leraas KM, Voytovich K, Wheeler G, Brennan P, Fitch J, Kelly BJ, McGrath SD, Miller AR, White P, Magrini V, Wilson RK, Mardis ER, Lauwers GY, Baker PB, Cottrell CE. Gastroblastoma with a novel EWSR1-CTBP1 fusion presenting in adolescence. Genes Chromosomes Cancer. 2021 Sep; 60: 640-646.
Balis F, Green DM, Anderson C, Cook S, Dhillon J, Gow K, Hiniker S, Jasty-Rao R, Lin C, Lovvorn H, MacEwan I, Martinez-Agosto J, Mullen E, Murphy ES, Ranalli M, Rhee D, Rokitka D, Tracy EL, Vern-Gross T, Walsh MF, Walz A, Wickiser J, Zapala M, Berardi RA, Hughes M. Wilms Tumor (Nephroblastoma), Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021 Aug 1; 19: 945-977.
Ahmad H, Halleran DR, Vardanyan J, Mathieu W, Stanek J, Ranalli M, Levitt MA, Wood RJ, Aldrink JH. Functional fecal and urinary outcomes after sacrococcygeal mass resection in pediatric patients. J Pediatr Surg. 2021 Jun; 56: 1142-1147.
Fisher RS, Kenney AE, Fults MZ, Manring S, Rodriguez EM, Desjardins L, Rausch JR, Young-Saleme T, Ranalli MA, Vannatta K, Compas BE, Gerhardt CA. Longitudinal understanding of prognosis among adolescents with cancer. Pediatr Blood Cancer. 2021 Mar; 68: e28826.
Perisa MP, Storey M, Streby KA, Ranalli MA, Skeens M, Shah N. Cabozantinib for relapsed neuroblastoma: Single institution case series. Pediatr Blood Cancer. 2020 Jul; 67: e28317.
Mansfield SA, Lamb MG, Stanek JR, Arnold MA, Ranalli M, Aldrink JH. Renal Tumors in Children and Young Adults Older Than 5 Years of Age. J Pediatr Hematol Oncol. 2020 May; 42: 287-291.
Streby KA, Currier MA, Triplet M, Ott K, Dishman DJ, Vaughan MR, Ranalli MA, Setty B, Skeens MA, Whiteside S, Yeager ND, Haworth KB, Simpson K, Conner J, Cripe TP. First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial. Mol Ther. 2019 Nov 6; 27: 1930-1938.
Rinehardt H, Ranalli M, Diefenbach KA, Arnold MA, Espinosa Morazan A, Aldrink JH. Multifocal Appendiceal Carcinoid Tumor in an Adolescent: A Case Report and Review of the Literature. J Pediatr Hematol Oncol. 2019 Oct; 41: 568-570.
Mansfield SA, Dykes M, Adler B, Uffman JC, Sales S, Ranalli M, Kenney BD, Aldrink JH. Improving Quality of Chest Computed Tomography for Evaluation of Pediatric Malignancies. Pediatr Qual Saf. 2019 May-Jun; 4: e166.
Schechter T, Perez-Albuerne E, Lin TF, Irwin MS, Essa M, Desai AV, Frangoul H, Yanik G, Dupuis LL, Jacobsohn D, Kletzel M, Ranalli M, Soni S, Seif AE, Grupp S, Dvorak CC. Veno-occlusive disease after high-dose busulfan-melphalan in neuroblastoma. Bone Marrow Transplant. 2018 Sep 4;
View More Publications
Education
Date of Appointment at Nationwide Children’s Hospital: 11/16/1999
Board Certifications
Pediatric Hematology Oncology Pediatrics
Fellowship
Childrens Memorial Hospital (Chicago)
Date Completed: 06/30/1999
Residency
Children’s Hospital of Philadelphia
Date Completed: 06/30/1992
Internship
Children’s Hospital of Philadelphia
Date Completed: 06/30/1990
Medical School
University of Chicago Pritzker School of Medicine
Date Completed: 06/15/1989
Contact Information
Pediatrics
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Mark A. Ranalli
Biography
Dr. Ranalli’s clinical and academic interests include the treatment of neuroblastoma, primary renal tumors, germ cell malignancies, melanoma, and the use of novel therapies for refractory malignancies. He is the medical director of the Surgical Oncology Clinic and oversees the Embryonal Tumor Program. Dr. Ranalli received his medical degree from the University of Chicago Pritzker School of Medicine. He completed his residency at Children’s Hospital of Philadelphia and his fellowship training at Children’s Memorial Hospital in Chicago. Dr. Ranalli currently leads the therapeutic MIBG program and is the Nationwide Children’s site principal investigator for the Children’s oncology group.
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Nationwide Children’s Hospital Toledo
Mansfield Close To Home Center
Academic and Clinical Areas
Surgical Oncology Clinic
Co-Director
Melanoma & Pigmented Lesion Clinic
Physician Lead
Pediatric Thyroid Program
Physician Team
Hematology/Oncology & BMT
Physician Team
Hematology, Oncology and BMT Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
Research
Publications
Reed S, Treinen C, Shah N, Ranalli M, Olshefski R. Utilizing a Quality Improvement Strategy to Increase Faculty Engagement with Resident Learning Goals. Acad Pediatr. 2022 Sep 16;
Koo SC, Schieffer KM, Lee K, Gupta A, Pfau RB, Avenarius MR, Stonerock E, LaHaye S, Fitch J, Setty BA, Roberts R, Ranalli M, Conces MR, Bu F, Mardis ER, Cottrell CE. EGFR internal tandem duplications in fusion-negative congenital and neonatal spindle cell tumors. Genes Chromosomes Cancer. 2022 Jul 7;
Miller KE, Wheeler G, LaHaye S, Schieffer KM, Cearlock S, Venkata LPR, Bravo AO, Grischow OE, Kelly BJ, White P, Pierson CR, Boué DR, Koo SC, Klawinski D, Ranalli MA, Shaikhouni A, Salloum R, Shatara M, Leonard JR, Wilson RK, Cottrell CE, Mardis ER, Koboldt DC. Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement. Front Oncol. 2022; 12: 932337.
Koo SC, LaHaye S, Kovari BP, Schieffer KM, Ranalli MA, Aldrink JH, Michalsky MP, Colace S, Miller KE, Bedrosian TA, Leraas KM, Voytovich K, Wheeler G, Brennan P, Fitch J, Kelly BJ, McGrath SD, Miller AR, White P, Magrini V, Wilson RK, Mardis ER, Lauwers GY, Baker PB, Cottrell CE. Gastroblastoma with a novel EWSR1-CTBP1 fusion presenting in adolescence. Genes Chromosomes Cancer. 2021 Sep; 60: 640-646.
Balis F, Green DM, Anderson C, Cook S, Dhillon J, Gow K, Hiniker S, Jasty-Rao R, Lin C, Lovvorn H, MacEwan I, Martinez-Agosto J, Mullen E, Murphy ES, Ranalli M, Rhee D, Rokitka D, Tracy EL, Vern-Gross T, Walsh MF, Walz A, Wickiser J, Zapala M, Berardi RA, Hughes M. Wilms Tumor (Nephroblastoma), Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021 Aug 1; 19: 945-977.
Ahmad H, Halleran DR, Vardanyan J, Mathieu W, Stanek J, Ranalli M, Levitt MA, Wood RJ, Aldrink JH. Functional fecal and urinary outcomes after sacrococcygeal mass resection in pediatric patients. J Pediatr Surg. 2021 Jun; 56: 1142-1147.
Fisher RS, Kenney AE, Fults MZ, Manring S, Rodriguez EM, Desjardins L, Rausch JR, Young-Saleme T, Ranalli MA, Vannatta K, Compas BE, Gerhardt CA. Longitudinal understanding of prognosis among adolescents with cancer. Pediatr Blood Cancer. 2021 Mar; 68: e28826.
Perisa MP, Storey M, Streby KA, Ranalli MA, Skeens M, Shah N. Cabozantinib for relapsed neuroblastoma: Single institution case series. Pediatr Blood Cancer. 2020 Jul; 67: e28317.
Mansfield SA, Lamb MG, Stanek JR, Arnold MA, Ranalli M, Aldrink JH. Renal Tumors in Children and Young Adults Older Than 5 Years of Age. J Pediatr Hematol Oncol. 2020 May; 42: 287-291.
Streby KA, Currier MA, Triplet M, Ott K, Dishman DJ, Vaughan MR, Ranalli MA, Setty B, Skeens MA, Whiteside S, Yeager ND, Haworth KB, Simpson K, Conner J, Cripe TP. First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial. Mol Ther. 2019 Nov 6; 27: 1930-1938.
Rinehardt H, Ranalli M, Diefenbach KA, Arnold MA, Espinosa Morazan A, Aldrink JH. Multifocal Appendiceal Carcinoid Tumor in an Adolescent: A Case Report and Review of the Literature. J Pediatr Hematol Oncol. 2019 Oct; 41: 568-570.
Mansfield SA, Dykes M, Adler B, Uffman JC, Sales S, Ranalli M, Kenney BD, Aldrink JH. Improving Quality of Chest Computed Tomography for Evaluation of Pediatric Malignancies. Pediatr Qual Saf. 2019 May-Jun; 4: e166.
Schechter T, Perez-Albuerne E, Lin TF, Irwin MS, Essa M, Desai AV, Frangoul H, Yanik G, Dupuis LL, Jacobsohn D, Kletzel M, Ranalli M, Soni S, Seif AE, Grupp S, Dvorak CC. Veno-occlusive disease after high-dose busulfan-melphalan in neuroblastoma. Bone Marrow Transplant. 2018 Sep 4;
View More Publications
Education
Date of Appointment at Nationwide Children’s Hospital: 11/16/1999
Board Certifications
Pediatric Hematology Oncology Pediatrics
Fellowship
Childrens Memorial Hospital (Chicago)
Date Completed: 06/30/1999
Residency
Children’s Hospital of Philadelphia
Date Completed: 06/30/1992
Internship
Children’s Hospital of Philadelphia
Date Completed: 06/30/1990
Medical School
University of Chicago Pritzker School of Medicine
Date Completed: 06/15/1989
Contact Information
Pediatrics
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Mark A. Ranalli
Contact Information
- Call us at:
- (614) 722-3550
- Fax us at:
- (614) 722-3369
- PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Mark A. Ranalli
Biography
Dr. Ranalli’s clinical and academic interests include the treatment of neuroblastoma, primary renal tumors, germ cell malignancies, melanoma, and the use of novel therapies for refractory malignancies. He is the medical director of the Surgical Oncology Clinic and oversees the Embryonal Tumor Program. Dr. Ranalli received his medical degree from the University of Chicago Pritzker School of Medicine. He completed his residency at Children’s Hospital of Philadelphia and his fellowship training at Children’s Memorial Hospital in Chicago. Dr. Ranalli currently leads the therapeutic MIBG program and is the Nationwide Children’s site principal investigator for the Children’s oncology group.
Biography
Dr. Ranalli’s clinical and academic interests include the treatment of neuroblastoma, primary renal tumors, germ cell malignancies, melanoma, and the use of novel therapies for refractory malignancies. He is the medical director of the Surgical Oncology Clinic and oversees the Embryonal Tumor Program. Dr. Ranalli received his medical degree from the University of Chicago Pritzker School of Medicine. He completed his residency at Children’s Hospital of Philadelphia and his fellowship training at Children’s Memorial Hospital in Chicago. Dr. Ranalli currently leads the therapeutic MIBG program and is the Nationwide Children’s site principal investigator for the Children’s oncology group.
Biography
Dr. Ranalli’s clinical and academic interests include the treatment of neuroblastoma, primary renal tumors, germ cell malignancies, melanoma, and the use of novel therapies for refractory malignancies. He is the medical director of the Surgical Oncology Clinic and oversees the Embryonal Tumor Program. Dr. Ranalli received his medical degree from the University of Chicago Pritzker School of Medicine. He completed his residency at Children’s Hospital of Philadelphia and his fellowship training at Children’s Memorial Hospital in Chicago. Dr. Ranalli currently leads the therapeutic MIBG program and is the Nationwide Children’s site principal investigator for the Children’s oncology group.
Dr. Ranalli’s clinical and academic interests include the treatment of neuroblastoma, primary renal tumors, germ cell malignancies, melanoma, and the use of novel therapies for refractory malignancies. He is the medical director of the Surgical Oncology Clinic and oversees the Embryonal Tumor Program. Dr. Ranalli received his medical degree from the University of Chicago Pritzker School of Medicine. He completed his residency at Children’s Hospital of Philadelphia and his fellowship training at Children’s Memorial Hospital in Chicago. Dr. Ranalli currently leads the therapeutic MIBG program and is the Nationwide Children’s site principal investigator for the Children’s oncology group.
Dr. Ranalli’s clinical and academic interests include the treatment of neuroblastoma, primary renal tumors, germ cell malignancies, melanoma, and the use of novel therapies for refractory malignancies. He is the medical director of the Surgical Oncology Clinic and oversees the Embryonal Tumor Program. Dr. Ranalli received his medical degree from the University of Chicago Pritzker School of Medicine. He completed his residency at Children’s Hospital of Philadelphia and his fellowship training at Children’s Memorial Hospital in Chicago. Dr. Ranalli currently leads the therapeutic MIBG program and is the Nationwide Children’s site principal investigator for the Children’s oncology group.
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Nationwide Children’s Hospital Toledo
Mansfield Close To Home Center
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Nationwide Children’s Hospital Toledo
Mansfield Close To Home Center
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Nationwide Children’s Hospital Toledo
Mansfield Close To Home Center
Locations
Main Campus of Nationwide Children’s Hospital
Nationwide Children’s Hospital Toledo
Mansfield Close To Home Center
Locations
Main Campus of Nationwide Children’s Hospital
Nationwide Children’s Hospital Toledo
Mansfield Close To Home Center
Locations
Main Campus of Nationwide Children’s Hospital
Nationwide Children’s Hospital Toledo
Mansfield Close To Home Center
- Main Campus of Nationwide Children’s Hospital
- Nationwide Children’s Hospital Toledo
- Mansfield Close To Home Center
Academic and Clinical Areas
Surgical Oncology Clinic
Co-Director
Melanoma & Pigmented Lesion Clinic
Physician Lead
Pediatric Thyroid Program
Physician Team
Hematology/Oncology & BMT
Physician Team
Hematology, Oncology and BMT Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
Academic and Clinical Areas
Surgical Oncology Clinic
Co-Director
Melanoma & Pigmented Lesion Clinic
Physician Lead
Pediatric Thyroid Program
Physician Team
Hematology/Oncology & BMT
Physician Team
Hematology, Oncology and BMT Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
Academic and Clinical Areas
Surgical Oncology Clinic
Co-Director
Melanoma & Pigmented Lesion Clinic
Physician Lead
Pediatric Thyroid Program
Physician Team
Hematology/Oncology & BMT
Physician Team
Hematology, Oncology and BMT Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
Surgical Oncology Clinic
Co-Director
Melanoma & Pigmented Lesion Clinic
Physician Lead
Pediatric Thyroid Program
Physician Team
Hematology/Oncology & BMT
Physician Team
Hematology, Oncology and BMT Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Hematology & Oncology
- Surgical Oncology Clinic
- Co-Director
- Melanoma & Pigmented Lesion Clinic
- Physician Lead
- Pediatric Thyroid Program
- Physician Team
- Hematology/Oncology & BMT
- Physician Team
- Hematology, Oncology and BMT Fellowship
- Faculty
- Primary Department
- Pediatrics
- Primary Section
- Hematology & Oncology
Research
Publications
Reed S, Treinen C, Shah N, Ranalli M, Olshefski R. Utilizing a Quality Improvement Strategy to Increase Faculty Engagement with Resident Learning Goals. Acad Pediatr. 2022 Sep 16;
Koo SC, Schieffer KM, Lee K, Gupta A, Pfau RB, Avenarius MR, Stonerock E, LaHaye S, Fitch J, Setty BA, Roberts R, Ranalli M, Conces MR, Bu F, Mardis ER, Cottrell CE. EGFR internal tandem duplications in fusion-negative congenital and neonatal spindle cell tumors. Genes Chromosomes Cancer. 2022 Jul 7;
Miller KE, Wheeler G, LaHaye S, Schieffer KM, Cearlock S, Venkata LPR, Bravo AO, Grischow OE, Kelly BJ, White P, Pierson CR, Boué DR, Koo SC, Klawinski D, Ranalli MA, Shaikhouni A, Salloum R, Shatara M, Leonard JR, Wilson RK, Cottrell CE, Mardis ER, Koboldt DC. Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement. Front Oncol. 2022; 12: 932337.
Koo SC, LaHaye S, Kovari BP, Schieffer KM, Ranalli MA, Aldrink JH, Michalsky MP, Colace S, Miller KE, Bedrosian TA, Leraas KM, Voytovich K, Wheeler G, Brennan P, Fitch J, Kelly BJ, McGrath SD, Miller AR, White P, Magrini V, Wilson RK, Mardis ER, Lauwers GY, Baker PB, Cottrell CE. Gastroblastoma with a novel EWSR1-CTBP1 fusion presenting in adolescence. Genes Chromosomes Cancer. 2021 Sep; 60: 640-646.
Balis F, Green DM, Anderson C, Cook S, Dhillon J, Gow K, Hiniker S, Jasty-Rao R, Lin C, Lovvorn H, MacEwan I, Martinez-Agosto J, Mullen E, Murphy ES, Ranalli M, Rhee D, Rokitka D, Tracy EL, Vern-Gross T, Walsh MF, Walz A, Wickiser J, Zapala M, Berardi RA, Hughes M. Wilms Tumor (Nephroblastoma), Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021 Aug 1; 19: 945-977.
Ahmad H, Halleran DR, Vardanyan J, Mathieu W, Stanek J, Ranalli M, Levitt MA, Wood RJ, Aldrink JH. Functional fecal and urinary outcomes after sacrococcygeal mass resection in pediatric patients. J Pediatr Surg. 2021 Jun; 56: 1142-1147.
Fisher RS, Kenney AE, Fults MZ, Manring S, Rodriguez EM, Desjardins L, Rausch JR, Young-Saleme T, Ranalli MA, Vannatta K, Compas BE, Gerhardt CA. Longitudinal understanding of prognosis among adolescents with cancer. Pediatr Blood Cancer. 2021 Mar; 68: e28826.
Perisa MP, Storey M, Streby KA, Ranalli MA, Skeens M, Shah N. Cabozantinib for relapsed neuroblastoma: Single institution case series. Pediatr Blood Cancer. 2020 Jul; 67: e28317.
Mansfield SA, Lamb MG, Stanek JR, Arnold MA, Ranalli M, Aldrink JH. Renal Tumors in Children and Young Adults Older Than 5 Years of Age. J Pediatr Hematol Oncol. 2020 May; 42: 287-291.
Streby KA, Currier MA, Triplet M, Ott K, Dishman DJ, Vaughan MR, Ranalli MA, Setty B, Skeens MA, Whiteside S, Yeager ND, Haworth KB, Simpson K, Conner J, Cripe TP. First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial. Mol Ther. 2019 Nov 6; 27: 1930-1938.
Rinehardt H, Ranalli M, Diefenbach KA, Arnold MA, Espinosa Morazan A, Aldrink JH. Multifocal Appendiceal Carcinoid Tumor in an Adolescent: A Case Report and Review of the Literature. J Pediatr Hematol Oncol. 2019 Oct; 41: 568-570.
Mansfield SA, Dykes M, Adler B, Uffman JC, Sales S, Ranalli M, Kenney BD, Aldrink JH. Improving Quality of Chest Computed Tomography for Evaluation of Pediatric Malignancies. Pediatr Qual Saf. 2019 May-Jun; 4: e166.
Schechter T, Perez-Albuerne E, Lin TF, Irwin MS, Essa M, Desai AV, Frangoul H, Yanik G, Dupuis LL, Jacobsohn D, Kletzel M, Ranalli M, Soni S, Seif AE, Grupp S, Dvorak CC. Veno-occlusive disease after high-dose busulfan-melphalan in neuroblastoma. Bone Marrow Transplant. 2018 Sep 4;
View More Publications
Research
Publications
Reed S, Treinen C, Shah N, Ranalli M, Olshefski R. Utilizing a Quality Improvement Strategy to Increase Faculty Engagement with Resident Learning Goals. Acad Pediatr. 2022 Sep 16;
Koo SC, Schieffer KM, Lee K, Gupta A, Pfau RB, Avenarius MR, Stonerock E, LaHaye S, Fitch J, Setty BA, Roberts R, Ranalli M, Conces MR, Bu F, Mardis ER, Cottrell CE. EGFR internal tandem duplications in fusion-negative congenital and neonatal spindle cell tumors. Genes Chromosomes Cancer. 2022 Jul 7;
Miller KE, Wheeler G, LaHaye S, Schieffer KM, Cearlock S, Venkata LPR, Bravo AO, Grischow OE, Kelly BJ, White P, Pierson CR, Boué DR, Koo SC, Klawinski D, Ranalli MA, Shaikhouni A, Salloum R, Shatara M, Leonard JR, Wilson RK, Cottrell CE, Mardis ER, Koboldt DC. Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement. Front Oncol. 2022; 12: 932337.
Koo SC, LaHaye S, Kovari BP, Schieffer KM, Ranalli MA, Aldrink JH, Michalsky MP, Colace S, Miller KE, Bedrosian TA, Leraas KM, Voytovich K, Wheeler G, Brennan P, Fitch J, Kelly BJ, McGrath SD, Miller AR, White P, Magrini V, Wilson RK, Mardis ER, Lauwers GY, Baker PB, Cottrell CE. Gastroblastoma with a novel EWSR1-CTBP1 fusion presenting in adolescence. Genes Chromosomes Cancer. 2021 Sep; 60: 640-646.
Balis F, Green DM, Anderson C, Cook S, Dhillon J, Gow K, Hiniker S, Jasty-Rao R, Lin C, Lovvorn H, MacEwan I, Martinez-Agosto J, Mullen E, Murphy ES, Ranalli M, Rhee D, Rokitka D, Tracy EL, Vern-Gross T, Walsh MF, Walz A, Wickiser J, Zapala M, Berardi RA, Hughes M. Wilms Tumor (Nephroblastoma), Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021 Aug 1; 19: 945-977.
Ahmad H, Halleran DR, Vardanyan J, Mathieu W, Stanek J, Ranalli M, Levitt MA, Wood RJ, Aldrink JH. Functional fecal and urinary outcomes after sacrococcygeal mass resection in pediatric patients. J Pediatr Surg. 2021 Jun; 56: 1142-1147.
Fisher RS, Kenney AE, Fults MZ, Manring S, Rodriguez EM, Desjardins L, Rausch JR, Young-Saleme T, Ranalli MA, Vannatta K, Compas BE, Gerhardt CA. Longitudinal understanding of prognosis among adolescents with cancer. Pediatr Blood Cancer. 2021 Mar; 68: e28826.
Perisa MP, Storey M, Streby KA, Ranalli MA, Skeens M, Shah N. Cabozantinib for relapsed neuroblastoma: Single institution case series. Pediatr Blood Cancer. 2020 Jul; 67: e28317.
Mansfield SA, Lamb MG, Stanek JR, Arnold MA, Ranalli M, Aldrink JH. Renal Tumors in Children and Young Adults Older Than 5 Years of Age. J Pediatr Hematol Oncol. 2020 May; 42: 287-291.
Streby KA, Currier MA, Triplet M, Ott K, Dishman DJ, Vaughan MR, Ranalli MA, Setty B, Skeens MA, Whiteside S, Yeager ND, Haworth KB, Simpson K, Conner J, Cripe TP. First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial. Mol Ther. 2019 Nov 6; 27: 1930-1938.
Rinehardt H, Ranalli M, Diefenbach KA, Arnold MA, Espinosa Morazan A, Aldrink JH. Multifocal Appendiceal Carcinoid Tumor in an Adolescent: A Case Report and Review of the Literature. J Pediatr Hematol Oncol. 2019 Oct; 41: 568-570.
Mansfield SA, Dykes M, Adler B, Uffman JC, Sales S, Ranalli M, Kenney BD, Aldrink JH. Improving Quality of Chest Computed Tomography for Evaluation of Pediatric Malignancies. Pediatr Qual Saf. 2019 May-Jun; 4: e166.
Schechter T, Perez-Albuerne E, Lin TF, Irwin MS, Essa M, Desai AV, Frangoul H, Yanik G, Dupuis LL, Jacobsohn D, Kletzel M, Ranalli M, Soni S, Seif AE, Grupp S, Dvorak CC. Veno-occlusive disease after high-dose busulfan-melphalan in neuroblastoma. Bone Marrow Transplant. 2018 Sep 4;
View More Publications
Research
Publications
Reed S, Treinen C, Shah N, Ranalli M, Olshefski R. Utilizing a Quality Improvement Strategy to Increase Faculty Engagement with Resident Learning Goals. Acad Pediatr. 2022 Sep 16;
Koo SC, Schieffer KM, Lee K, Gupta A, Pfau RB, Avenarius MR, Stonerock E, LaHaye S, Fitch J, Setty BA, Roberts R, Ranalli M, Conces MR, Bu F, Mardis ER, Cottrell CE. EGFR internal tandem duplications in fusion-negative congenital and neonatal spindle cell tumors. Genes Chromosomes Cancer. 2022 Jul 7;
Miller KE, Wheeler G, LaHaye S, Schieffer KM, Cearlock S, Venkata LPR, Bravo AO, Grischow OE, Kelly BJ, White P, Pierson CR, Boué DR, Koo SC, Klawinski D, Ranalli MA, Shaikhouni A, Salloum R, Shatara M, Leonard JR, Wilson RK, Cottrell CE, Mardis ER, Koboldt DC. Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement. Front Oncol. 2022; 12: 932337.
Koo SC, LaHaye S, Kovari BP, Schieffer KM, Ranalli MA, Aldrink JH, Michalsky MP, Colace S, Miller KE, Bedrosian TA, Leraas KM, Voytovich K, Wheeler G, Brennan P, Fitch J, Kelly BJ, McGrath SD, Miller AR, White P, Magrini V, Wilson RK, Mardis ER, Lauwers GY, Baker PB, Cottrell CE. Gastroblastoma with a novel EWSR1-CTBP1 fusion presenting in adolescence. Genes Chromosomes Cancer. 2021 Sep; 60: 640-646.
Balis F, Green DM, Anderson C, Cook S, Dhillon J, Gow K, Hiniker S, Jasty-Rao R, Lin C, Lovvorn H, MacEwan I, Martinez-Agosto J, Mullen E, Murphy ES, Ranalli M, Rhee D, Rokitka D, Tracy EL, Vern-Gross T, Walsh MF, Walz A, Wickiser J, Zapala M, Berardi RA, Hughes M. Wilms Tumor (Nephroblastoma), Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021 Aug 1; 19: 945-977.
Ahmad H, Halleran DR, Vardanyan J, Mathieu W, Stanek J, Ranalli M, Levitt MA, Wood RJ, Aldrink JH. Functional fecal and urinary outcomes after sacrococcygeal mass resection in pediatric patients. J Pediatr Surg. 2021 Jun; 56: 1142-1147.
Fisher RS, Kenney AE, Fults MZ, Manring S, Rodriguez EM, Desjardins L, Rausch JR, Young-Saleme T, Ranalli MA, Vannatta K, Compas BE, Gerhardt CA. Longitudinal understanding of prognosis among adolescents with cancer. Pediatr Blood Cancer. 2021 Mar; 68: e28826.
Perisa MP, Storey M, Streby KA, Ranalli MA, Skeens M, Shah N. Cabozantinib for relapsed neuroblastoma: Single institution case series. Pediatr Blood Cancer. 2020 Jul; 67: e28317.
Mansfield SA, Lamb MG, Stanek JR, Arnold MA, Ranalli M, Aldrink JH. Renal Tumors in Children and Young Adults Older Than 5 Years of Age. J Pediatr Hematol Oncol. 2020 May; 42: 287-291.
Streby KA, Currier MA, Triplet M, Ott K, Dishman DJ, Vaughan MR, Ranalli MA, Setty B, Skeens MA, Whiteside S, Yeager ND, Haworth KB, Simpson K, Conner J, Cripe TP. First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial. Mol Ther. 2019 Nov 6; 27: 1930-1938.
Rinehardt H, Ranalli M, Diefenbach KA, Arnold MA, Espinosa Morazan A, Aldrink JH. Multifocal Appendiceal Carcinoid Tumor in an Adolescent: A Case Report and Review of the Literature. J Pediatr Hematol Oncol. 2019 Oct; 41: 568-570.
Mansfield SA, Dykes M, Adler B, Uffman JC, Sales S, Ranalli M, Kenney BD, Aldrink JH. Improving Quality of Chest Computed Tomography for Evaluation of Pediatric Malignancies. Pediatr Qual Saf. 2019 May-Jun; 4: e166.
Schechter T, Perez-Albuerne E, Lin TF, Irwin MS, Essa M, Desai AV, Frangoul H, Yanik G, Dupuis LL, Jacobsohn D, Kletzel M, Ranalli M, Soni S, Seif AE, Grupp S, Dvorak CC. Veno-occlusive disease after high-dose busulfan-melphalan in neuroblastoma. Bone Marrow Transplant. 2018 Sep 4;
View More Publications
Publications
Reed S, Treinen C, Shah N, Ranalli M, Olshefski R. Utilizing a Quality Improvement Strategy to Increase Faculty Engagement with Resident Learning Goals. Acad Pediatr. 2022 Sep 16;
Koo SC, Schieffer KM, Lee K, Gupta A, Pfau RB, Avenarius MR, Stonerock E, LaHaye S, Fitch J, Setty BA, Roberts R, Ranalli M, Conces MR, Bu F, Mardis ER, Cottrell CE. EGFR internal tandem duplications in fusion-negative congenital and neonatal spindle cell tumors. Genes Chromosomes Cancer. 2022 Jul 7;
Miller KE, Wheeler G, LaHaye S, Schieffer KM, Cearlock S, Venkata LPR, Bravo AO, Grischow OE, Kelly BJ, White P, Pierson CR, Boué DR, Koo SC, Klawinski D, Ranalli MA, Shaikhouni A, Salloum R, Shatara M, Leonard JR, Wilson RK, Cottrell CE, Mardis ER, Koboldt DC. Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement. Front Oncol. 2022; 12: 932337.
Koo SC, LaHaye S, Kovari BP, Schieffer KM, Ranalli MA, Aldrink JH, Michalsky MP, Colace S, Miller KE, Bedrosian TA, Leraas KM, Voytovich K, Wheeler G, Brennan P, Fitch J, Kelly BJ, McGrath SD, Miller AR, White P, Magrini V, Wilson RK, Mardis ER, Lauwers GY, Baker PB, Cottrell CE. Gastroblastoma with a novel EWSR1-CTBP1 fusion presenting in adolescence. Genes Chromosomes Cancer. 2021 Sep; 60: 640-646.
Balis F, Green DM, Anderson C, Cook S, Dhillon J, Gow K, Hiniker S, Jasty-Rao R, Lin C, Lovvorn H, MacEwan I, Martinez-Agosto J, Mullen E, Murphy ES, Ranalli M, Rhee D, Rokitka D, Tracy EL, Vern-Gross T, Walsh MF, Walz A, Wickiser J, Zapala M, Berardi RA, Hughes M. Wilms Tumor (Nephroblastoma), Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021 Aug 1; 19: 945-977.
Ahmad H, Halleran DR, Vardanyan J, Mathieu W, Stanek J, Ranalli M, Levitt MA, Wood RJ, Aldrink JH. Functional fecal and urinary outcomes after sacrococcygeal mass resection in pediatric patients. J Pediatr Surg. 2021 Jun; 56: 1142-1147.
Fisher RS, Kenney AE, Fults MZ, Manring S, Rodriguez EM, Desjardins L, Rausch JR, Young-Saleme T, Ranalli MA, Vannatta K, Compas BE, Gerhardt CA. Longitudinal understanding of prognosis among adolescents with cancer. Pediatr Blood Cancer. 2021 Mar; 68: e28826.
Perisa MP, Storey M, Streby KA, Ranalli MA, Skeens M, Shah N. Cabozantinib for relapsed neuroblastoma: Single institution case series. Pediatr Blood Cancer. 2020 Jul; 67: e28317.
Mansfield SA, Lamb MG, Stanek JR, Arnold MA, Ranalli M, Aldrink JH. Renal Tumors in Children and Young Adults Older Than 5 Years of Age. J Pediatr Hematol Oncol. 2020 May; 42: 287-291.
Streby KA, Currier MA, Triplet M, Ott K, Dishman DJ, Vaughan MR, Ranalli MA, Setty B, Skeens MA, Whiteside S, Yeager ND, Haworth KB, Simpson K, Conner J, Cripe TP. First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial. Mol Ther. 2019 Nov 6; 27: 1930-1938.
Rinehardt H, Ranalli M, Diefenbach KA, Arnold MA, Espinosa Morazan A, Aldrink JH. Multifocal Appendiceal Carcinoid Tumor in an Adolescent: A Case Report and Review of the Literature. J Pediatr Hematol Oncol. 2019 Oct; 41: 568-570.
Mansfield SA, Dykes M, Adler B, Uffman JC, Sales S, Ranalli M, Kenney BD, Aldrink JH. Improving Quality of Chest Computed Tomography for Evaluation of Pediatric Malignancies. Pediatr Qual Saf. 2019 May-Jun; 4: e166.
Schechter T, Perez-Albuerne E, Lin TF, Irwin MS, Essa M, Desai AV, Frangoul H, Yanik G, Dupuis LL, Jacobsohn D, Kletzel M, Ranalli M, Soni S, Seif AE, Grupp S, Dvorak CC. Veno-occlusive disease after high-dose busulfan-melphalan in neuroblastoma. Bone Marrow Transplant. 2018 Sep 4;
View More Publications
Reed S, Treinen C, Shah N, Ranalli M, Olshefski R. Utilizing a Quality Improvement Strategy to Increase Faculty Engagement with Resident Learning Goals. Acad Pediatr. 2022 Sep 16;
Koo SC, Schieffer KM, Lee K, Gupta A, Pfau RB, Avenarius MR, Stonerock E, LaHaye S, Fitch J, Setty BA, Roberts R, Ranalli M, Conces MR, Bu F, Mardis ER, Cottrell CE. EGFR internal tandem duplications in fusion-negative congenital and neonatal spindle cell tumors. Genes Chromosomes Cancer. 2022 Jul 7;
Miller KE, Wheeler G, LaHaye S, Schieffer KM, Cearlock S, Venkata LPR, Bravo AO, Grischow OE, Kelly BJ, White P, Pierson CR, Boué DR, Koo SC, Klawinski D, Ranalli MA, Shaikhouni A, Salloum R, Shatara M, Leonard JR, Wilson RK, Cottrell CE, Mardis ER, Koboldt DC. Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement. Front Oncol. 2022; 12: 932337.
Koo SC, LaHaye S, Kovari BP, Schieffer KM, Ranalli MA, Aldrink JH, Michalsky MP, Colace S, Miller KE, Bedrosian TA, Leraas KM, Voytovich K, Wheeler G, Brennan P, Fitch J, Kelly BJ, McGrath SD, Miller AR, White P, Magrini V, Wilson RK, Mardis ER, Lauwers GY, Baker PB, Cottrell CE. Gastroblastoma with a novel EWSR1-CTBP1 fusion presenting in adolescence. Genes Chromosomes Cancer. 2021 Sep; 60: 640-646.
Balis F, Green DM, Anderson C, Cook S, Dhillon J, Gow K, Hiniker S, Jasty-Rao R, Lin C, Lovvorn H, MacEwan I, Martinez-Agosto J, Mullen E, Murphy ES, Ranalli M, Rhee D, Rokitka D, Tracy EL, Vern-Gross T, Walsh MF, Walz A, Wickiser J, Zapala M, Berardi RA, Hughes M. Wilms Tumor (Nephroblastoma), Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021 Aug 1; 19: 945-977.
Ahmad H, Halleran DR, Vardanyan J, Mathieu W, Stanek J, Ranalli M, Levitt MA, Wood RJ, Aldrink JH. Functional fecal and urinary outcomes after sacrococcygeal mass resection in pediatric patients. J Pediatr Surg. 2021 Jun; 56: 1142-1147.
Fisher RS, Kenney AE, Fults MZ, Manring S, Rodriguez EM, Desjardins L, Rausch JR, Young-Saleme T, Ranalli MA, Vannatta K, Compas BE, Gerhardt CA. Longitudinal understanding of prognosis among adolescents with cancer. Pediatr Blood Cancer. 2021 Mar; 68: e28826.
Perisa MP, Storey M, Streby KA, Ranalli MA, Skeens M, Shah N. Cabozantinib for relapsed neuroblastoma: Single institution case series. Pediatr Blood Cancer. 2020 Jul; 67: e28317.
Mansfield SA, Lamb MG, Stanek JR, Arnold MA, Ranalli M, Aldrink JH. Renal Tumors in Children and Young Adults Older Than 5 Years of Age. J Pediatr Hematol Oncol. 2020 May; 42: 287-291.
Streby KA, Currier MA, Triplet M, Ott K, Dishman DJ, Vaughan MR, Ranalli MA, Setty B, Skeens MA, Whiteside S, Yeager ND, Haworth KB, Simpson K, Conner J, Cripe TP. First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial. Mol Ther. 2019 Nov 6; 27: 1930-1938.
Rinehardt H, Ranalli M, Diefenbach KA, Arnold MA, Espinosa Morazan A, Aldrink JH. Multifocal Appendiceal Carcinoid Tumor in an Adolescent: A Case Report and Review of the Literature. J Pediatr Hematol Oncol. 2019 Oct; 41: 568-570.
Mansfield SA, Dykes M, Adler B, Uffman JC, Sales S, Ranalli M, Kenney BD, Aldrink JH. Improving Quality of Chest Computed Tomography for Evaluation of Pediatric Malignancies. Pediatr Qual Saf. 2019 May-Jun; 4: e166.
Schechter T, Perez-Albuerne E, Lin TF, Irwin MS, Essa M, Desai AV, Frangoul H, Yanik G, Dupuis LL, Jacobsohn D, Kletzel M, Ranalli M, Soni S, Seif AE, Grupp S, Dvorak CC. Veno-occlusive disease after high-dose busulfan-melphalan in neuroblastoma. Bone Marrow Transplant. 2018 Sep 4;
View More Publications
- Reed S, Treinen C, Shah N, Ranalli M, Olshefski R. Utilizing a Quality Improvement Strategy to Increase Faculty Engagement with Resident Learning Goals. Acad Pediatr. 2022 Sep 16;
- Koo SC, Schieffer KM, Lee K, Gupta A, Pfau RB, Avenarius MR, Stonerock E, LaHaye S, Fitch J, Setty BA, Roberts R, Ranalli M, Conces MR, Bu F, Mardis ER, Cottrell CE. EGFR internal tandem duplications in fusion-negative congenital and neonatal spindle cell tumors. Genes Chromosomes Cancer. 2022 Jul 7;
- Miller KE, Wheeler G, LaHaye S, Schieffer KM, Cearlock S, Venkata LPR, Bravo AO, Grischow OE, Kelly BJ, White P, Pierson CR, Boué DR, Koo SC, Klawinski D, Ranalli MA, Shaikhouni A, Salloum R, Shatara M, Leonard JR, Wilson RK, Cottrell CE, Mardis ER, Koboldt DC. Molecular Heterogeneity in Pediatric Malignant Rhabdoid Tumors in Patients With Multi-Organ Involvement. Front Oncol. 2022; 12: 932337.
- Koo SC, LaHaye S, Kovari BP, Schieffer KM, Ranalli MA, Aldrink JH, Michalsky MP, Colace S, Miller KE, Bedrosian TA, Leraas KM, Voytovich K, Wheeler G, Brennan P, Fitch J, Kelly BJ, McGrath SD, Miller AR, White P, Magrini V, Wilson RK, Mardis ER, Lauwers GY, Baker PB, Cottrell CE. Gastroblastoma with a novel EWSR1-CTBP1 fusion presenting in adolescence. Genes Chromosomes Cancer. 2021 Sep; 60: 640-646.
- Balis F, Green DM, Anderson C, Cook S, Dhillon J, Gow K, Hiniker S, Jasty-Rao R, Lin C, Lovvorn H, MacEwan I, Martinez-Agosto J, Mullen E, Murphy ES, Ranalli M, Rhee D, Rokitka D, Tracy EL, Vern-Gross T, Walsh MF, Walz A, Wickiser J, Zapala M, Berardi RA, Hughes M. Wilms Tumor (Nephroblastoma), Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021 Aug 1; 19: 945-977.
- Ahmad H, Halleran DR, Vardanyan J, Mathieu W, Stanek J, Ranalli M, Levitt MA, Wood RJ, Aldrink JH. Functional fecal and urinary outcomes after sacrococcygeal mass resection in pediatric patients. J Pediatr Surg. 2021 Jun; 56: 1142-1147.
- Fisher RS, Kenney AE, Fults MZ, Manring S, Rodriguez EM, Desjardins L, Rausch JR, Young-Saleme T, Ranalli MA, Vannatta K, Compas BE, Gerhardt CA. Longitudinal understanding of prognosis among adolescents with cancer. Pediatr Blood Cancer. 2021 Mar; 68: e28826.
- Perisa MP, Storey M, Streby KA, Ranalli MA, Skeens M, Shah N. Cabozantinib for relapsed neuroblastoma: Single institution case series. Pediatr Blood Cancer. 2020 Jul; 67: e28317.
- Mansfield SA, Lamb MG, Stanek JR, Arnold MA, Ranalli M, Aldrink JH. Renal Tumors in Children and Young Adults Older Than 5 Years of Age. J Pediatr Hematol Oncol. 2020 May; 42: 287-291.
- Streby KA, Currier MA, Triplet M, Ott K, Dishman DJ, Vaughan MR, Ranalli MA, Setty B, Skeens MA, Whiteside S, Yeager ND, Haworth KB, Simpson K, Conner J, Cripe TP. First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial. Mol Ther. 2019 Nov 6; 27: 1930-1938.
- Rinehardt H, Ranalli M, Diefenbach KA, Arnold MA, Espinosa Morazan A, Aldrink JH. Multifocal Appendiceal Carcinoid Tumor in an Adolescent: A Case Report and Review of the Literature. J Pediatr Hematol Oncol. 2019 Oct; 41: 568-570.
- Mansfield SA, Dykes M, Adler B, Uffman JC, Sales S, Ranalli M, Kenney BD, Aldrink JH. Improving Quality of Chest Computed Tomography for Evaluation of Pediatric Malignancies. Pediatr Qual Saf. 2019 May-Jun; 4: e166.
- Schechter T, Perez-Albuerne E, Lin TF, Irwin MS, Essa M, Desai AV, Frangoul H, Yanik G, Dupuis LL, Jacobsohn D, Kletzel M, Ranalli M, Soni S, Seif AE, Grupp S, Dvorak CC. Veno-occlusive disease after high-dose busulfan-melphalan in neuroblastoma. Bone Marrow Transplant. 2018 Sep 4;
Education
Date of Appointment at Nationwide Children’s Hospital: 11/16/1999
Board Certifications
Pediatric Hematology Oncology Pediatrics
Fellowship
Childrens Memorial Hospital (Chicago)
Date Completed: 06/30/1999
Residency
Children’s Hospital of Philadelphia
Date Completed: 06/30/1992
Internship
Children’s Hospital of Philadelphia
Date Completed: 06/30/1990
Medical School
University of Chicago Pritzker School of Medicine
Date Completed: 06/15/1989
Education
Date of Appointment at Nationwide Children’s Hospital: 11/16/1999
Board Certifications
Pediatric Hematology Oncology Pediatrics
Fellowship
Childrens Memorial Hospital (Chicago)
Date Completed: 06/30/1999
Residency
Children’s Hospital of Philadelphia
Date Completed: 06/30/1992
Internship
Children’s Hospital of Philadelphia
Date Completed: 06/30/1990
Medical School
University of Chicago Pritzker School of Medicine
Date Completed: 06/15/1989
Education
Date of Appointment at Nationwide Children’s Hospital: 11/16/1999
Board Certifications
Pediatric Hematology Oncology Pediatrics
Fellowship
Childrens Memorial Hospital (Chicago)
Date Completed: 06/30/1999
Residency
Children’s Hospital of Philadelphia
Date Completed: 06/30/1992
Internship
Children’s Hospital of Philadelphia
Date Completed: 06/30/1990
Medical School
University of Chicago Pritzker School of Medicine
Date Completed: 06/15/1989
Date of Appointment at Nationwide Children’s Hospital: 11/16/1999
Board Certifications
Pediatric Hematology Oncology Pediatrics
Fellowship
Childrens Memorial Hospital (Chicago)
Date Completed: 06/30/1999
Residency
Children’s Hospital of Philadelphia
Date Completed: 06/30/1992
Internship
Children’s Hospital of Philadelphia
Date Completed: 06/30/1990
Medical School
University of Chicago Pritzker School of Medicine
Date Completed: 06/15/1989
Date of Appointment at Nationwide Children’s Hospital: 11/16/1999
Board Certifications
Pediatric Hematology Oncology Pediatrics
Fellowship
Childrens Memorial Hospital (Chicago)
Date Completed: 06/30/1999
Residency
Children’s Hospital of Philadelphia
Date Completed: 06/30/1992
Internship
Children’s Hospital of Philadelphia
Date Completed: 06/30/1990
Medical School
University of Chicago Pritzker School of Medicine
Date Completed: 06/15/1989
- Pediatric Hematology Oncology
- Pediatrics
Contact Information
Pediatrics
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Pediatrics
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Pediatrics
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Pediatrics
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
Call us at: (614) 722-3550
Fax us at: (614) 722-3369
Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)
- Call us at:
- (614) 722-3550
- Fax us at:
- (614) 722-3369
- Hematology & Oncology700 Children’s DrColumbus, OH 43205 (map)